Evidence map›Paper›PMID 36962095›Full record

ArticlePLOS global public health2022

Out-of-pocket costs near end of life in low- and middle-income countries: A systematic review.

Eleanor Reid, Arunangshu Ghoshal, Aisha Khalil, Jingjing Jiang, Charles Normand, Alexandria Brackett, Peter May

Open access · goldFull text read
In one paragraph

Article in PLOS global public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 4 countries.

Eleanor ReidDepartment of Emergency Medicine, Yale University School of Medicine, New Haven, Connecticut, United States of America.ORCID https://orcid.org/0000-0002-5758-4903
Arunangshu GhoshalTata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India.ORCID https://orcid.org/0000-0001-9975-2568
Aisha KhalilINFAQ Foundation, Karachi, Pakistan.ORCID https://orcid.org/0000-0003-1767-0978
Jingjing JiangCentre for Health Policy and Management, Trinity College Dublin, Dublin, Ireland.ORCID https://orcid.org/0000-0002-6839-5147
Charles NormandCentre for Health Policy and Management, Trinity College Dublin, Dublin, Ireland.
Alexandria BrackettCushing/Whitney Medical Library, Yale University, New Haven, Connecticut, United States of America.
Peter MayCentre for Health Policy and Management, Trinity College Dublin, Dublin, Ireland.ORCID https://orcid.org/0000-0001-8501-6500
Trinity College Dublin · IEHomi Bhabha National Institute · INKing's College London · GBWhitney Museum of American Art · USYale University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGlobally, there is a rise in chronic disease, including cancer, major organ failure and dementias. Patients and their families in low- and middle-income countries (LMICs) pay a high proportion of medical costs out of pocket (OOP), and a diagnosis of serious illness often has catastrophic financial consequences. We therefore conducted a review of the literature to establish what is known about OOP costs near end of life in LMICs.

aimsTo identify, organise and report the evidence on out-of-pocket costs in adult end-of-life populations in LMIC.

methodsA systematic search of 8 databases and a hand search of relevant systematic reviews and grey literature was performed. Two independent reviewers screened titles and abstracts, assessed papers for eligibility and extracted data. The review was registered with PROSPERO and adhered to the Preferred Reporting items for Systematic Reviews and Meta Analyses. The Mixed Methods Appraisal Tool was used to assess quality. The Wagstaff taxonomy was used to describe OOP.

resultsAfter deduplication, 9,343 studies were screened, of which 51 were read and rejected as full texts, and 12 were included in the final review. OOP costs increased with advanced illness and disease severity. The main drivers of OOP were medications and hospitalizations, with high but variable percentages of the affected populations reporting financial catastrophe, lost income, foregone education and other pressures.

conclusionDespite a small number of included studies and heterogeneity in methodology and reporting, it is clear that OOP costs for care near end of life in LMIC represent an important source of catastrophic health expenditures and impoverishment. This suggests a role for widespread, targeted efforts to avoid poverty traps. Financial protection policies for those suffering from incurable disease and future research on the macro- and micro- economics of palliative care delivery in LMIC are greatly needed.

Identifiers

PMID36962095
PMCPMC10022295
OpenAlexW4205980546

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read59
reference markers read30
identifiers read11
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.